Dry Eye Management Strategies: Appropriate Treatment-Decisio -

Name: Dry Eye Management Strategies: Appropriate Treatment-Decision Making in Patients with Dry Eye Webinar Part 1
Uploaded: 2018-03-27T08:00:00+00:00
Duration: 1 h 11 min 9 s
Description: This educational activity is supported by an independent medical educational grant from Shire.

Media formats available:

Details

Presenters

Overview
This educational activity is supported by an independent medical educational grant from Shire.
Learning Objectives
Upon completion of this activity, the participant should be able to: • Discuss the prevalence of dry eye disease and the related signs and symptoms of patients • Develop a differential diagnosis for patients with complaints of dry eye • Propose an individualized treatment plan for patients using current U.S. Food and Drug Administration-approved therapies • Evaluate how dry eye disease can complicate surgical outcomes and how best to manage dry eye disease in these states • Differentiate the need for constant maintenance and ongoing ophthalmic care for the various dry eye disease treatments.
Accreditation
Accreditation Statement Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
COPE CE ACCREDITATION DESIGNATION STATEMENT
In cooperation with Evolve Medical Education LLC, the University of Houston College of Optometry has reviewed and endorsed this course. This course is COPE approved for 1.0 hours of CE credit for optometrists. COPE Course ID: 57162-AS COPE Activity ID: 115224
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
Terry Kim, MD Professor of Ophthalmology Duke University School of Medicine Chief, Cornea and External Disease Division Director, Refractive Surgery Service Duke University Eye Center Francis S. Mah, MD Director, Cornea and External Disease Co-Director, Refractive Surgery Scripps Clinic La Jolla, CA Terry Kim, MD has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Acucela; Aerie Pharmaceuticals; Alcon; Allergan plc; Avedro; Avellino Labs; Baush & Lomb; Blephex; CoDa/Ocunexus Therapeutics; Kala Pharmaceuticals; Ocular Therapeutix; Omeros; Powervision; Presbyopia Therapies; Shire; Sightlife Surgical Inc.; Simple Contacts; Tear Lab; and Tear Science. Stockholder: Kala Pharmaceuticals; NovaBay Pharmaceuticals; Ocular Therapeutix; Omeros; Sightlife Surgical, Inc.; Simple Contacts; and TearScience. Francis S. Mah, MD has had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant and Speaker: Alcon; Allergan plc; AMO; Baush & Lomb; and Shire. He has received Grant/Research Support: Allergan plc; and Shire. Editorial Support DisclosuresErin K. Fletcher, MIT, director of compliance and education, Evolve; and Michelle Dalton, writer have no financial relationships with commercial interests. Jaya Kumar, MD, peer reviewer, has no financial relationships with commercial interests.
Disclaimer
OFF-LABEL STATEMENT This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. DISCLAIMER The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, or Shire.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 03/27/2018
Expiration Date: 03/12/2021